NCT03767764View on ClinicalTrials.gov

Yliver as a Test to Early Diagnose HCC

CompletedOBSERVATIONAL
Enrollment

190

Participants

Timeline

Start Date

December 27, 2018

Primary Completion Date

April 1, 2020

Study Completion Date

September 1, 2020

Conditions
Hepatocellular Carcinoma
Interventions
DIAGNOSTIC_TEST

Test Yliver

Test Yliver is used to detect autoantibodies against alpha fetoprotein in serum by an ELISA technique

Trial Locations (1)

08208

Corporacion Parc Taulí, Sabadell

Sponsors
All Listed Sponsors
lead

Corporacion Parc Tauli

OTHER

NCT03767764 - Yliver as a Test to Early Diagnose HCC | Biotech Hunter | Biotech Hunter